Seattle Biomedical Research Institute donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page CIDResearch
Websitehttp://www.seattlebiomed.org/
Twitter usernameCIDResearch
Wikipedia pagehttps://en.wikipedia.org/wiki/Center_for_Infectious_Disease_Research
Instagram usernamecidresearch

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 44 500,000 1,679,482 -1,932,868 -41,577 500 10,000 150,000 500,000 711,972 1,024,815 2,970,000 4,399,331 19,366,968
Global health 43 556,555 1,718,191 -1,932,868 -41,577 500 9,500 192,213 556,555 711,972 1,043,390 2,970,000 4,399,331 19,366,968
FIXME 1 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000

Donation amounts by donor and year for donee Seattle Biomedical Research Institute

Donor Total 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 1990
Bill and Melinda Gates Foundation (filter this donee) 73,882,212.40 -374,009.00 5,500.00 8,500.00 -1,262,114.34 5,157,769.00 1,769,910.00 10,528,895.00 3,559,859.06 6,096,103.65 2,322,819.00 17,540,200.00 28,528,780.03 0.00
MacArthur Foundation (filter this donee) 15,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15,000.00
Total 73,897,212.40 -374,009.00 5,500.00 8,500.00 -1,262,114.34 5,157,769.00 1,769,910.00 10,528,895.00 3,559,859.06 6,096,103.65 2,322,819.00 17,540,200.00 28,528,780.03 15,000.00

Full list of donations in reverse chronological order (44 donations)

DonorAmount (current USD)Amount rank (out of 44)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation-374,009.00432017-06-09Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- for the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies, in order to, as part of a Systems Biology/ Systems Immunology Consortium, uncover signatures, correlates, and mechanisms of protectio; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation5,000.00342016-02-17Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to provide for general operating support. 2016 Annual Gala for Global Health. Investment start date: 2/17/2016 to end date: 3/18/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation500.00352016-01-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide for general operating support. Starting Gates Thank You December 2015. Investment start date: 1/6/2016 to end date: 1/7/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation500.00352015-09-30Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- To provide for general operating support. Starting Gates 4/8/2015. Investment start date: 9/30/2015 to end date: 10/29/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation7,500.00332015-08-25Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support. 2015 Gala for Global Health. Investment start date: 8/25/2015 to end date: 9/18/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation500.00352015-01-21Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to support the Starting Gates partnership. Starting Gates 10/15/14. Investment start date: 1/21/2015 to end date: 2/5/2015. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation-341,059.34422014-10-28Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-41,577.00402014-05-01Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to support the Global Health Research Congress. Global Health Research Congress. Investment start date: 10/14/2009 to end date: 5/9/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,043,390.00132014-05-01Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to support the general operations of Seattle Biomedical Research Institute. General Operating Support. Investment start date: 5/1/2014 to end date: 12/31/2016. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-1,932,868.00442014-03-31Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation10,000.00312014-02-13Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- for general operating support. 2014 Passport to Global Health Celebration. Investment start date: 2/13/2014 to end date: 3/7/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation4,399,331.0052013-10-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- for the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies, in order to, as part of a Systems Biology/ Systems Immunology Consortium, uncover signatures, correlates, and mechanisms of protectio; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation500.00352013-09-26Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- for general operating support. StartingGates 9/17/2013. Investment start date: 9/26/2013 to end date: 10/25/2013. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation757,938.00172013-05-24Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop methodology with the goal of identifying novel antigens that can induce sterile, long-lasting protection against malaria liver stage and thus infection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation764,952.00162012-10-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to facilitate identification of correlates of vaccine-induced immunity and (eventually) protection from TB, enabling iterative design of improved TB vaccines that will play a critical role in the fight to end this deadly disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation448,403.00242012-08-14Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for proteomic identification of novel surface and secreted antigens as targets to block malaria infection.; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation556,555.00222012-05-22Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop methodology with the goal of identifying further novel antigens that can induce sterile, long-lasting protection against malaria liver stage and thus infection; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation1,203,410.00122011-11-01Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to determine whether wild-type liver stage P. falciparum parasites can induce anti-infection immunity in humans if killed prior to the formation, and release of blood-stage parasites; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation379,820.00252011-10-31Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop tools that will enable the study of Plasmodium vivax malaria. Development of gametocyte and liver stage specific markers for Plasmodium vivax. Investment start date: 10/31/2011 to end date: 6/30/2014. Grantee name: Seattle Biomedical Research I; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation8,945,665.0032011-03-23Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,423,943.62112010-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation711,971.81182010-11-18Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation711,971.81182010-11-18Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation711,971.81182010-11-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation3,005,236.0072009-10-28Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to determine whether wild-type liver stage P. falciparum parasites can induce anti-infection immunity in humans if killed prior to the formation, and release of blood-stage parasites; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation150,000.00272009-10-14Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to support the Global Health Research Congress. Global Health Research Congress. Investment start date: 10/14/2009 to end date: 5/9/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-63,225.35412009-09-24Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to support the "Diagnosing pregnancy malaria: Detecting infection, predicting disease" conference; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation2,994,593.0082009-08-27Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to fight tuberculosis by forging new ways to develop antibiotics that dramatically shorten therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation9,500.00322009-03-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- for general operating support. for general operating support. Investment start date: 3/17/2009 to end date: 3/17/2010. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation559,712.00212008-11-10Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to enhance the sustainability of SBRI's global health discovery and translational research for the alleviation of global infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,024,815.00142008-09-26Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new opportunities to identify and validate new targets for anti-malarial drugs; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation500,000.00232008-09-16Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to increase student awareness of global health issues and inspire them to enter global health fields; Aid type: Project-type interventions. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation118,059.00292008-09-12Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to support the "Diagnosing pregnancy malaria: Detecting infection, predicting disease" conference; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation120,233.00282008-04-16Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to support planning activities for the Global Health Research Congress. Global Health Research Congress Planning Grant. Investment start date: 3/22/2008 to end date: 8/21/2009. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation8,998,623.0022007-10-05Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop immunogens for a vaccine that will prevent pregnancy malaria globally. Pregnancy Malaria Initiative. Investment start date: 10/1/2007 to end date: 4/30/2014. Grantee name: Seattle Biomedical Research Institute; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation1,021,401.00152007-10-01Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to plan a Worldwide Antimalarial Drug Resistance Network (WARN) as a global resource to ensure efficacious use of antimalarial drugs; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation7,520,176.0042007-09-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to fight tuberculosis by forging new ways to develop antibiotics that dramatically shorten therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation192,213.00262006-08-23Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to fund a meeting to initiate creation of a public, web-based database of current and historical patterns of drug resistance in malaria parasites; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-30,400.97392006-08-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to fund a meeting to initiate creation of a public, web-based database of current and historical patterns of drug resistance in malaria parasites; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation2,970,000.0092006-08-04Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,970,000.0092006-08-04Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,060,000.0062006-08-04Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- for general operating support. Expansion Activities. Investment start date: 7/24/2006 to end date: 7/31/2012. Grantee name: Seattle Biomedical Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation19,366,968.0012006-06-14Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to use novel computational and biological approaches for the design and evaluation of HIV vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
MacArthur Foundation15,000.00301990FIXMEhttps://www.macfound.org/grants/-- For a workshop on the molecular biology of leishmaniasis and trypanosomiases. Affected countries: United States; affected states: Washington; affected cities: Seattle.